|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: | |||||
| Depreciation | |||||
| Amortization of deferred financing costs | |||||
| (Benefit) provision for deferred income taxes | |||||
| Change in fair value of equity securities | |||||
| Change in fair value of derivative instruments | |||||
| Loss on the sale of investments | |||||
| Stock based compensation | |||||
| (Gain) loss on disposal of property, plant, and equipment | |||||
| Impairment of intangible asset | |||||
| Noncash interest expense | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Accounts receivable – related parties | |||||
| Inventory | |||||
| Income tax receivable | |||||
| Prepaid expenses | |||||
| Prepaid expenses – related party | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accounts payable – related parties | |||||
| Dividends payable | |||||
| Accrued expenses and other current liabilities | |||||
| Accrued expenses and other current liabilities – related parties | |||||
| Deferred revenue | |||||
| Other noncurrent liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Collateralization of derivative instruments | |||||
| Purchase of marketable securities | |||||
| Proceeds from the sale of marketable securities | |||||
| Proceeds from the sale of property, plant, and equipment | |||||
| Proceeds from the sale of intangible assets | |||||
| Capital expenditures | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Minimum tax withholding on stock options exercised | |||||
| Deferred financing costs | |||||
| Proceeds from the issuance of stock | |||||
| Payment of dividends | |||||
| Net cash used in financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Noncash investing and financing activities: | |||||
| Noncash capital expenditures included in accounts payable | |||||
| Noncash operating leases | |||||
| Noncash items incurred for dividends | |||||
| Dividends payable | |||||
Loading...